Charles River Laboratories International, Inc. (FRA:RV6)

Market Cap	7.07B +27.0%
Revenue (ttm)	3.41B -0.9%
Net Income	-122.69M
EPS	-2.48
Shares Out	n/a
PE Ratio	n/a
Forward PE	15.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	4
Open	153.10
Previous Close	154.95
Day's Range	153.10 - 153.10
52-Week Range	95.08 - 193.70
Beta	n/a
RSI	56.27
Earnings Date	May 7, 2026

About FRA:RV6

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, ins...

• Industry: Commercial Physical and Biological Research
• Founded: 1947
• Employees: 19,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RV6

Financial Performance

Financial numbers in USD